ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
31.05
+0.05 (0.16%)
Apr 24, 2026, 1:29 PM EDT - Market open
ArriVent BioPharma Market Cap
ArriVent BioPharma has a market cap or net worth of $1.37 billion as of April 24, 2026. Its market cap has increased by 147.53% in one year.
Market Cap
1.37B
Enterprise Value
1.06B
1-Year Change
147.53%
Ranking
Category
Stock Price
$31.05
Market Cap Chart
Since the IPO on January 26, 2024, ArriVent BioPharma's market cap has increased from $575.22M to $1.37B, an increase of 138.60%. That is a compound annual growth rate of 47.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 1.37B | 64.97% |
| Dec 31, 2025 | 830.58M | -7.48% |
| Dec 31, 2024 | 897.69M | 56.06% |
| Jan 26, 2024 | 575.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AnaptysBio | 1.46B |
| Ardelyx | 1.46B |
| Iovance Biotherapeutics | 1.43B |
| Viridian Therapeutics | 1.43B |
| Maze Therapeutics | 1.41B |
| Wave Life Sciences | 1.37B |
| Novavax | 1.35B |
| Corvus Pharmaceuticals | 1.35B |